An interesting article about the new Alzheimer drug in which two members of the FDA outside advisory committee resigned because they were against the approval of this drug. They felt that the drug, which provides nominal improvement, was foreordained for approval. The cost of this drug is expected to be around $56,000/year.


https://www.msn.com/en-us/news/us/two-members...d=msedgntp